查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1376219

葡萄糖胺市場規模、佔有率、趨勢分析報告：按產品、按應用、按地區、細分市場預測，2023-2030

Glucosamine Market Size, Share & Trends Analysis Report By Product (Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, Others), By Application (Supplement, Food & Beverages), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 70 Pages | 商品交期: 2-10個工作天內

價格

葡萄糖胺市場成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球葡萄糖胺市場預計將達到 13.098 億美元。

預計2023年至2030年年複合成長率為5.2%。擴大該食品在營養補充生產中的應用，以幫助消費者預防骨關節炎，預計在未來年度推動需求。

素食消費者數量的增加，特別是在包括美國在內的已開發國家，預計將成為預測期內該行業的另一個促進因素。該產品主要由蝦和蟹等甲殼類動物製成，但嘉吉和 Cyanotech 透過從真菌黑麴菌中提取成分，率先推出了素食葡萄糖胺。

人口成長、醫療保健行業的快速成長以及消費者對關節和骨骼健康的認知預計將推動葡萄糖胺在各種食品和飲料中的使用。此外，對歐洲食品和飲料製造產品使用法規結構的支持預計也將推動未來年度的產業成長。然而，魚油和含 omega-3替代的增加可能會對預測期內的產品需求造成挑戰。

葡萄糖胺市場報告亮點

  • 2022 年，葡萄糖胺硫酸鹽業務佔最大收益佔有率，達到 61.1%。硫酸鹽葡萄糖胺是營養補充和食品中最廣泛使用的葡萄糖胺型態之一。
  • 鹽酸葡萄糖胺業務預計在預測期內將以 5.2% 的複合年複合成長率成長，位居第二。鹽酸葡萄糖胺是一種常用作食品營養補充以支持關節健康的化合物。
  • 2022 年，補充劑行業佔據最大的銷售佔有率，達到 79.9%。這些補充劑主要由貝類製成，包括蝦和蟹，但隨著過敏案例的增加和素食者數量的增加，尤其是在美國，製造商正在用真菌和其他植物來源生產產品。我們正在開始開發產品。
  • 亞太地區佔據市場主導地位，2022 年佔最大銷售佔有率，達 47.9%。亞太地區包括中國、日本、印度和澳洲等國家，人口眾多且擴張迅速，全部區域的健康和保健意識也正在快速提高。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 葡萄糖胺市場變數、趨勢、範圍

  • 市場體系展望
  • 普及和成長前景圖
  • 價值鏈分析
  • 法律規範
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
    • 產業機會與挑戰
  • 葡萄糖胺市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 供應商組合分析

  • 供應商名單
  • Kraljic Matrix
  • 採購最佳實踐
  • 談判策略

第5章 葡萄糖胺：產品估算與趨勢分析

  • 葡萄糖胺市場：要點
  • 葡萄糖胺市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 葡萄糖胺硫酸鹽
  • 鹽酸葡萄糖
  • N-乙醯葡萄糖胺
  • 其他

第6章 葡萄糖胺：使用量估算與趨勢分析

  • 葡萄糖胺市場：要點
  • 葡萄糖胺市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 補充
  • 食品與飲品
  • 其他

第7章 葡萄糖胺市場：區域估計與趨勢分析

  • 區域展望
  • 按地區分類的葡萄糖胺市場：要點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
  • 亞太地區
    • 日本
    • 中國
    • 印度
  • 中美洲和南美洲
    • 巴西
  • 中東/非洲
    • 沙烏地阿拉伯
    • 南非

第8章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Koyo Chemical Industry Co., Ltd
    • Laboratoires Expanscience
    • Nutramax Laboratories Consumer Care, Inc.
    • Amway
    • CELLMARK AB.
    • Alfa Chemical Group
    • Cargill, Incorporated
    • Dalian Lijian Bio-Technology Development Co. Ltd
    • SimplySupplements
Product Code: 978-1-68038-091-0

Glucosamine Market Growth & Trends:

The global glucosamine market is expected to reach USD 1309.8 million by 2030, according to a new report by Grand View Research, Inc.. It is expected to expand at a CAGR of 5.2% from 2023 to 2030. The growing application scope of the product in the manufacturing of nutritional supplements, which aid in the prevention of osteoarthritis among consumers is expected to fuel demand over the next seven years.

An increasing number of vegan consumers particularly in developed countries including the U.S. is expected to be another driver for the industry over the forecast period. The product is primarily manufactured from crustaceans including shrimp and crab; however, Cargill and Cyanotech have pioneered vegetarian glucosamine by extracting the ingredient from 'aspergillus niger' fungi.

The increasing population, rapidly growing healthcare industry, and consumer awareness regarding joint and bone health is expected to fuel the use of glucosamine in various food & beverage products. In addition, supporting regulatory framework in Europe regarding product use in the manufacturing of food & beverages is expected to propel industry growth over the next seven years. However, an increasing number of substitutes including fish oil and omega-3 may challenge product demand over the forecast period.

Glucosamine Market Report Highlights:

  • The glucosamine sulfate segment accounted for the largest revenue share of 61.1% in 2022. Glucosamine sulfate has been one of the most widely used forms of glucosamine in dietary supplements and pharmaceuticals
  • The glucosamine hydrochloride segment is expected to grow at the second-fastest CAGR of 5.2% over the forecast period. Glucosamine hydrochloride is a compound commonly used as a dietary supplement to support joint health
  • The supplement segment held the largest revenue share of 79.9% in 2022. These supplements are mainly manufactured from crustaceans including shrimp and crabs, however, increasing instances of allergy and a rising number of vegans, particularly in the U.S., have led manufacturers to develop the product from fungi and other plant sources
  • Asia Pacific dominated the market and accounted for the largest revenue share of 47.9% in 2022. The Asia Pacific region, encompassing countries like China, Japan, India, and Australia, boasts a substantial and expanding population, with a simultaneous surge in health and wellness awareness across the area

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Glucosamine Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
  • 3.5. Market Dynamics
    • 3.5.1. Market Driver Analysis
    • 3.5.2. Market restraint analysis
    • 3.5.3. Industry opportunities & challenges
  • 3.6. Glucosamines Market Analysis Tools
    • 3.6.1. Industry Analysis - Porter's
      • 3.6.1.1. Supplier power
      • 3.6.1.2. Buyer power
      • 3.6.1.3. Substitution threat
      • 3.6.1.4. Threat of new entrant
      • 3.6.1.5. Competitive rivalry
    • 3.6.2. PESTEL Analysis
      • 3.6.2.1. Political landscape
      • 3.6.2.2. Technological landscape
      • 3.6.2.3. Economic landscape
      • 3.6.2.4. Social landscape
      • 3.6.2.5. Environmental landscape
      • 3.6.2.6. Legal landscape

Chapter 4. Supplier Portfolio Analysis

  • 4.1. List of Suppliers
  • 4.2. Kraljic Matrix
  • 4.3. Sourcing Best Practices
  • 4.4. Negotiation Strategies

Chapter 5. Glucosamine: Product Estimates & Trend Analysis

  • 5.1. Glucosamine Market: Key Takeaways
  • 5.2. Glucosamine Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Glucosamine Sulfate
    • 5.3.1. Glucosamine sulfate market estimates and forecasts, 2018 to 2030 (USD Million, Tons)
  • 5.4. Glucosamine Hydrochloride
    • 5.4.1. Glucosamine hydrochloride market estimates and forecasts, 2018 to 2030 (USD Million, Tons)
  • 5.5. N-acetyl glucosamine
    • 5.5.1. N-acetyl glucosamine market estimates and forecasts, 2018 to 2030 (USD Million, Tons)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million, Tons)

Chapter 6. Glucosamine: Application Estimates & Trend Analysis

  • 6.1. Glucosamine Market: Key Takeaways
  • 6.2. Glucosamine Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Supplement
    • 6.3.1. Supplement market estimates and forecasts, 2018 to 2030 (USD Million, Tons)
  • 6.4. Food and Beverage
    • 6.4.1. Food and beverage market estimates and forecasts, 2018 to 2030 (USD Million, Tons)
  • 6.5. Others
    • 6.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million, Tons)

Chapter 7. Glucosamine Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Glucosamine Market by Region: Key Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. Germany
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Central & South America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. Saudi Arabia
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Koyo Chemical Industry Co., Ltd
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Laboratoires Expanscience
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Nutramax Laboratories Consumer Care, Inc.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Amway
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. CELLMARK AB.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Alfa Chemical Group
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Cargill, Incorporated
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Dalian Lijian Bio-Technology Development Co. Ltd
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. SimplySupplements
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 3 North America Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 4 North America Glucosamine Market, By Region, 2018 - 2030 (USD Million, Tons)
  • Table 5 U.S. Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 6 U.S. Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 7 Canada Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 8 Canada Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 9 Mexico Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 10 Mexico Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 11 Europe Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 12 Europe Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 13 Europe Glucosamine Market, By Region, 2018 - 2030 (USD Million, Tons)
  • Table 14 Germany Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 15 Germany Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 16 UK Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 17 UK Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 18 France Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 19 France Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 20 Italy Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 21 Italy Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 22 Spain Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 23 Spain Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 24 Asia Pacific Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 25 Asia Pacific Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 26 Asia Pacific Glucosamine Market, By Region, 2018 - 2030 (USD Million, Tons)
  • Table 27 China Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 28 China Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 29 Japan Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 30 Japan Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 31 India Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 32 India Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 33 Central & South America Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 34 Central & South America Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 35 Central & South America Glucosamine Market, By Region, 2018 - 2030 (USD Million, Tons)
  • Table 36 Brazil Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 37 Brazil Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 38 Middle East and Africa Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 39 Middle East and Africa Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 40 Middle East and Africa Glucosamine Market, By Region, 2018 - 2030 (USD Million, Tons)
  • Table 41 South Africa Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 42 South Africa Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)
  • Table 43 Saudi Arabia Glucosamine Market, By Product, 2018 - 2030 (USD Million, Tons)
  • Table 44 Saudi Arabia Glucosamine Market, By Application, 2018 - 2030 (USD Million, Tons)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Glucosamine: Market outlook
  • Fig. 9 Glucosamine: Competitive Insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Glucosamine market driver impact
  • Fig. 15 Glucosamine market restraint impact
  • Fig. 16 Glucosamine Market Strategic Initiatives Analysis
  • Fig. 17 Glucosamine market: Product movement analysis
  • Fig. 18 Glucosamine market: Product outlook and key takeaways
  • Fig. 19 Glucosamine sulfate market estimates and forecasts, 2018 - 2030
  • Fig. 20 Glucosamine hydrochloride market estimates and forecasts, 2018 - 2030
  • Fig. 21 N-acetyl glucosamine market estimates and forecasts, 2018 - 2030
  • Fig. 22 Others glucosamine market estimates and forecasts, 2018 - 2030
  • Fig. 23 Glucosamine market: Application movement analysis
  • Fig. 24 Glucosamine market: Application outlook and key takeaways
  • Fig. 25 Supplement market estimates and forecasts, 2018 - 2030
  • Fig. 26 Food and beverage market estimates and forecasts, 2018 - 2030
  • Fig. 27 Others market estimates and forecasts, 2018 - 2030
  • Fig. 28 Global glucosamine market: Regional movement analysis
  • Fig. 29 Global glucosamine market: Regional outlook and key takeaways
  • Fig. 30 North America market estimates and forecasts, 2018 - 2030
  • Fig. 31 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 32 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 33 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 34 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 35 UK market estimates and forecasts, 2018 - 2030
  • Fig. 36 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 37 France market estimates and forecasts, 2018 - 2030
  • Fig. 38 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 39 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 40 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 41 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 42 China market estimates and forecasts, 2018 - 2030
  • Fig. 43 India market estimates and forecasts, 2018 - 2030
  • Fig. 44 Central & South America market estimates and forecasts, 2018 - 2030
  • Fig. 45 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 46 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 47 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 48 South Africa market estimates and forecasts, 2018 - 2030